Liquidia Technologies
Liquidia Technologies
To improve the quality of human life.
United States of America | Community Development |Overview
Liquidia Technologies is developing highly precise particle based vaccines and therapeutics for the prevention and treatment of human disease. Combining a deep understanding of particle based drug development with breakthrough small molecule and biological therapeutics Liquidia is engineering vaccines and therapies that have the potential to dramatically improve the quality of human life.
Industry |
Legal Structure |
Operating Status |
Employees |
Operating | 51 - 200 employees |
Funding and Financing Rounds
Feb, 2011 / Series C + / PRI / Equity
Undisclosed
Team
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
Impact Reports & Metrics
Offices
Headquarters
419 Davis Drive, Suite 100
Morrisville, North Carolina 27560
United States of America